APO vs. CME: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at APO and CME, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
With APO at 74.68 billion USD and CME at 101.53 billion USD, their market capitalizations sit in the same ballpark.
APO’s beta of 1.65 points to much larger expected swings compared to CME’s calmer 0.47, suggesting both higher upside and downside potential.
| Symbol | APO | CME |
|---|---|---|
| Company Name | Apollo Global Management, Inc. | CME Group Inc. |
| Country | US | US |
| Sector | Financial Services | Financial Services |
| Industry | Asset Management - Global | Financial - Data & Stock Exchanges |
| CEO | Mr. Marc Jeffrey Rowan | Mr. Terrence A. Duffy |
| Price | 130.68 USD | 281.74 USD |
| Market Cap | 74.68 billion USD | 101.53 billion USD |
| Beta | 1.65 | 0.47 |
| Exchange | NYSE | NASDAQ |
| IPO Date | March 30, 2011 | December 6, 2002 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of APO and CME over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
The section examines key financial ratios to assess the valuation of APO and CME based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.
- APO posts a negative forward PEG of -0.21, hinting at anticipated earnings decline, whereas CME at 4.40 has projections for stable or growing earnings.
| Symbol | APO | CME |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 21.36 | 28.29 |
| Forward PEG Ratio (TTM) | -0.21 | 4.40 |
| Price-to-Sales Ratio (P/S, TTM) | 3.03 | 16.16 |
| Price-to-Book Ratio (P/B, TTM) | 4.27 | 3.75 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 21.02 | 26.54 |
| EV-to-EBITDA (TTM) | 9.21 | 21.58 |
| EV-to-Sales (TTM) | 2.92 | 16.48 |
| EV-to-Free Cash Flow (TTM) | 20.25 | 27.06 |
Dividend Comparison
CME stands out with a 3.73% dividend yield—around 157% above APO’s 1.45%—highlighting its emphasis on generous payouts.
| Symbol | APO | CME |
|---|---|---|
| Dividend Yield (TTM) | 1.45% | 3.73% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of APO and CME, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- APO’s current ratio of 0.80 signals a possible liquidity squeeze, while CME at 1.02 comfortably covers its short-term obligations.
- APO’s quick ratio of 0.80 suggests it may struggle to cover immediate liabilities without selling inventory or raising cash, whereas CME at 1.02 maintains a comfortable buffer of liquid assets.
| Symbol | APO | CME |
|---|---|---|
| Current Ratio (TTM) | 0.80 | 1.02 |
| Quick Ratio (TTM) | 0.80 | 1.02 |
| Debt-to-Equity Ratio (TTM) | 0.59 | 0.13 |
| Debt-to-Assets Ratio (TTM) | 0.03 | 0.02 |
| Interest Coverage Ratio (TTM) | 21.30 | 33.72 |